These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24162189)

  • 1. ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets.
    Carlos AR; Escandell JM; Kotsantis P; Suwaki N; Bouwman P; Badie S; Folio C; Benitez J; Gomez-Lopez G; Pisano DG; Jonkers J; Tarsounas M
    Nat Commun; 2013; 4():2697. PubMed ID: 24162189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
    Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
    Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
    Chen Z; Carracedo A; Lin HK; Koutcher JA; Behrendt N; Egia A; Alimonti A; Carver BS; Gerald W; Teruya-Feldstein J; Loda M; Pandolfi PP
    Sci Signal; 2009 Aug; 2(84):ra44. PubMed ID: 19690330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress.
    Pauklin S; Kristjuhan A; Maimets T; Jaks V
    Biochem Biophys Res Commun; 2005 Aug; 334(2):386-94. PubMed ID: 16004968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic ras and p53 cooperate to induce cellular senescence.
    Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
    Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I; Murga M; Zubiaga A; Serrano M
    Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway.
    Shamanin VA; Androphy EJ
    Mol Cell Biol; 2004 Mar; 24(5):2144-52. PubMed ID: 14966292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.
    Hasan MK; Yaguchi T; Sugihara T; Kumar PK; Taira K; Reddel RR; Kaul SC; Wadhwa R
    J Biol Chem; 2002 Oct; 277(40):37765-70. PubMed ID: 12154087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
    Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
    Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
    Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R
    Genes Dev; 2002 Mar; 16(6):681-6. PubMed ID: 11914273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children.
    Wilda M; Bruch J; Harder L; Rawer D; Reiter A; Borkhardt A; Woessmann W
    Leukemia; 2004 Mar; 18(3):584-8. PubMed ID: 14712292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
    Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
    J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
    Aslanian A; Iaquinta PJ; Verona R; Lees JA
    Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb.
    Zeng Y; Kotake Y; Pei XH; Smith MD; Xiong Y
    Cancer Res; 2011 Apr; 71(7):2781-92. PubMed ID: 21447739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.
    Kortlever RM; Higgins PJ; Bernards R
    Nat Cell Biol; 2006 Aug; 8(8):877-84. PubMed ID: 16862142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of arf tumor suppressor in spermatogonia facilitates meiotic progression in male germ cells.
    Churchman ML; Roig I; Jasin M; Keeney S; Sherr CJ
    PLoS Genet; 2011 Jul; 7(7):e1002157. PubMed ID: 21811412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.